The negative correlations between 17-OHPE and E2 levels and FEI and positive correlation between 17-OHPE and SHBG seen in hyperandrogenemic PCOS in the current study indicated that estrogen can modulate steroidogenic pathways in these patients. This evidence concerns the gene SHBG and polycystic ovary syndrome.